Primary Recipient

EPIVAX, INC.

Amount

$243,561.00

Award Date

9/27/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

The major goal of this new research program (1R21AI078800-01) is to develop an improved platform for targeted HIV vaccine delivery to DCs using a novel non-tolerogenic áDEC-205 antibody (áDEC-205). The promise of this new technology is that it m